Denali Therapeutics
DNLI
DNLI
210 hedge funds and large institutions have $2.51B invested in Denali Therapeutics in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 76 increasing their positions, 69 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
1% more capital invested
Capital invested by funds: $2.49B → $2.51B (+$25.8M)
0% more funds holding
Funds holding: 209 → 210 (+1)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
210
Holding in Top 10
5
Calls
$2.5M
Puts
$2.46M
Top Buyers
| 1 | +$64.4M | |
| 2 | +$30.8M | |
| 3 | +$26.6M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$23.1M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$20.4M |
Top Sellers
| 1 | -$29M | |
| 2 | -$24.4M | |
| 3 | -$21.1M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$20.1M |
| 5 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
-$19.6M |